Cardiovascular
Raw Deal for European Women with Coronary Artery Disease
Caroline Daly
The Euroheart survey has found significant differences in both diagnosis and treatment of heart disease in women as compared with men. Audio Medica asked Caroline Daly of London’s Royal Brompton Hospital about the clinical implications.
Click here for all the interviews from ESC 2005
Similar Interviews
Eicosapentaenoic Acid: Prevention of Coronary Artery Disease A 20 000-person study of eicosapentaenoic acid supplements gave solid scientific support for EPA use to prevent cardiovascular events among
Protective Cardiovascular Benefit for Women on HRT For Natural Menopause
George Sopko
REFERENCE: Abstract 3771, American Heart Association Scientific Sessions, 4-7 November, 2007, Orlando, Florida
Pexelizumab Reduces Mortality in High Risk Coronary Artery By-Pass Patients
Peter Smith, Duke University Medical Center, Durham, NC
Late Breaking Clinical Trials, ACC Atlanta 2006, Sunday 12th March 2006
The drug pexelizumab,
Post a comment